Literature DB >> 22941579

Asymptomatic prospective and retrospective cohorts with metal-on-metal hip arthroplasty indicate acquired lymphocyte reactivity varies with metal ion levels on a group basis.

Nadim J Hallab1, Marco Caicedo, Kyron McAllister, Anastasia Skipor, Harlan Amstutz, Joshua J Jacobs.   

Abstract

Some tissues from metal-on-metal (MoM) hip arthroplasty revisions have shown evidence of adaptive-immune reactivity (i.e., excessive peri-implant lymphocyte infiltration/activation). We hypothesized that, prior to symptoms, some people with MoM hip arthroplasty will develop quantifiable metal-induced lymphocyte reactivity responses related to peripheral metal ion levels. We tested three cohorts (Group 1: n = 21 prospective longitudinal MoM hip arthroplasty; Group 2: n = 17 retrospective MoM hip arthroplasty; and Group 3: n = 20 controls without implants). We compared implant position, metal-ion release, and immuno-reactivity. MoM cohorts had elevated (p < 0.01) amounts of serum Co and Cr compared to controls as early as 3 months post-op (Group 1:1.2 ppb Co, 1.5 ppb Cr; Group 2: 3.4 ppb Co, 5.4 ppb Cr; Group 3: 0.01 ppb Co, 0.1 ppb Cr). However, only after 1-4 years post-op did 56% of Group 1 develop metal-reactivity (vs. 5% pre-op, metal-LTT, SI > 2), compared with 76% of Group 2, and 15% of Group 3 controls (patch testing was a poor diagnostic indicator with only 1/21 Group 1 positive). Higher cup-abduction angles (50° vs. 40°) in Group 1 were associated with higher serum Cr (p < 0.07). However, sub-optimal cup-anteversion angles (9° vs. 20°) had higher serum Co (p < 0.08). Serum Cr and Co were significantly elevated in reactive versus non-reactive Group-1 participants (p < 0.04). CD4+CD69+ T-helper lymphocytes (but not CD8+) and IL-1β, IL-12, and IL-6 cytokines were all significantly elevated in metal-reactive versus non-reactive Group 1 participants. Our results showed that lymphocyte reactivity to metals can develop within the first 1-4 years after MoM arthroplasty in asymptomatic patients and lags increases in metal ion levels. This increased metal reactivity was more prevalent in those individuals with extreme cup angles and higher amounts of circulating metal.
Copyright © 2012 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22941579      PMCID: PMC3534831          DOI: 10.1002/jor.22214

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  32 in total

1.  Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues.

Authors:  Ilaria Roato; Davide Caldo; Lucia D'Amico; Patrizia D'Amelio; Laura Godio; Salvatore Patanè; Franco Astore; Guido Grappiolo; Maurizio Boggio; Roberto Scagnelli; Luigi Molfetta; Riccardo Ferracini
Journal:  Biomaterials       Date:  2010-07-17       Impact factor: 12.479

2.  Metallosis after contemporary metal-on-metal total hip arthroplasty. Five to nine-year follow-up.

Authors:  P Korovessis; G Petsinis; M Repanti; T Repantis
Journal:  J Bone Joint Surg Am       Date:  2006-06       Impact factor: 5.284

3.  Early osteolysis following second-generation metal-on-metal hip replacement.

Authors:  Youn-Soo Park; Young-Wan Moon; Seung-Jae Lim; Jun-Mo Yang; Geunghwan Ahn; Yoon-La Choi
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

4.  The discrimination between nickel-sensitive and non-nickel-sensitive subjects by an in vitro lymphocyte transformation test.

Authors:  K M Everness; D J Gawkrodger; P A Botham; J A Hunter
Journal:  Br J Dermatol       Date:  1990-03       Impact factor: 9.302

5.  Effects of soluble metals on human peri-implant cells.

Authors:  Nadim James Hallab; Shelley Anderson; Marco Caicedo; Amee Brasher; Katalin Mikecz; Joshua J Jacobs
Journal:  J Biomed Mater Res A       Date:  2005-07-01       Impact factor: 4.396

6.  An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements.

Authors:  A P Davies; H G Willert; P A Campbell; I D Learmonth; C P Case
Journal:  J Bone Joint Surg Am       Date:  2005-01       Impact factor: 5.284

7.  Lymphocyte proliferation responses in patients with pseudotumors following metal-on-metal hip resurfacing arthroplasty.

Authors:  Young-Min Kwon; Peter Thomas; Burkhard Summer; Hemant Pandit; Adrian Taylor; David Beard; David W Murray; Harinderjit S Gill
Journal:  J Orthop Res       Date:  2010-04       Impact factor: 3.494

8.  Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study.

Authors:  J J Jacobs; A K Skipor; L M Patterson; N J Hallab; W G Paprosky; J Black; J O Galante
Journal:  J Bone Joint Surg Am       Date:  1998-10       Impact factor: 5.284

9.  Circulating levels of cobalt and chromium from metal-on-metal hip replacement are associated with CD8+ T-cell lymphopenia.

Authors:  A J Hart; J A Skinner; P Winship; N Faria; E Kulinskaya; D Webster; S Muirhead-Allwood; C H Aldam; H Anwar; J J Powell
Journal:  J Bone Joint Surg Br       Date:  2009-06

10.  A review of the biologic effects of spine implant debris: Fact from fiction.

Authors:  Nadim James Hallab
Journal:  SAS J       Date:  2009-12-01
View more
  12 in total

1.  CORR Insights(®): do patients with a failed metal-on-metal hip implant with a pseudotumor present differences in their peripheral blood lymphocyte subpopulations?

Authors:  Nadim James Hallab
Journal:  Clin Orthop Relat Res       Date:  2015-12       Impact factor: 4.176

2.  Frank Stinchfield Award: Identification of the At-risk Genotype for Development of Pseudotumors Around Metal-on-metal THAs.

Authors:  Brett K J Kilb; Andrew P Kurmis; Michael Parry; Karen Sherwood; Paul Keown; Bassam A Masri; Clive P Duncan; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

3.  Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability.

Authors:  Jodi R Schilz; K J Reddy; Sreejayan Nair; Thomas E Johnson; Ronald B Tjalkens; Kem P Krueger; Suzanne Clark
Journal:  J Vis Exp       Date:  2015-06-21       Impact factor: 1.355

Review 4.  Metallic Implants Used in Lumbar Interbody Fusion.

Authors:  Jakub Litak; Michał Szymoniuk; Wojciech Czyżewski; Zofia Hoffman; Joanna Litak; Leon Sakwa; Piotr Kamieniak
Journal:  Materials (Basel)       Date:  2022-05-20       Impact factor: 3.748

5.  [In vitro analysis of the impact of metal ions on human lymphocyte cultures].

Authors:  S Hagmann; J Kirsch; J P Kretzer; B Moradi
Journal:  Orthopade       Date:  2013-08       Impact factor: 1.087

6.  High metal ion levels after use of the ASR™ device correlate with development of pseudotumors and T cell activation.

Authors:  Nils P Hailer; Mats Bengtsson; Christina Lundberg; Jan Milbrink
Journal:  Clin Orthop Relat Res       Date:  2013-10-01       Impact factor: 4.176

7.  Increased expression of inducible co-stimulator on CD4+ T-cells in the peripheral blood and synovial fluid of patients with failed hip arthroplasties.

Authors:  P A Revell; G S Matharu; S Mittal; P B Pynsent; C D Buckley; M P Revell
Journal:  Bone Joint Res       Date:  2016-02       Impact factor: 5.853

Review 8.  Chemokines Associated with Pathologic Responses to Orthopedic Implant Debris.

Authors:  Nadim J Hallab; Joshua J Jacobs
Journal:  Front Endocrinol (Lausanne)       Date:  2017-01-19       Impact factor: 5.555

9.  CoCrMo alloy vs. UHMWPE Particulate Implant Debris Induces Sex Dependent Aseptic Osteolysis Responses In Vivo using a Murine Model.

Authors:  Stefan Landgraeber; Lauryn Samelko; Kyron McAllister; Sebastian Putz; Joshua J Jacobs; Nadim James Hallab
Journal:  Open Orthop J       Date:  2018-03-30

10.  Do Battlefield Injury-acquired Indwelling Metal Fragments Induce Metal Immunogenicity?

Authors:  Lauryn Samelko; Joseph Petfield; Kyron McAllister; Joseph Hsu; Michael Hawkinson; Joshua J Jacobs; Nadim J Hallab
Journal:  Clin Orthop Relat Res       Date:  2020-04       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.